Fig. 3From: The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)The E protein of SARS-CoV-2 does not restrict the replication of HSV-1. HEK293 cells were left untransfected or transfected with the empty vector (pUC-19) or a vector expressing the SARS-CoV-2 E protein. At 24Â h post-transfection, cells were inoculated with HSV-1 (0.01 pfu/cell). Cells were harvested at 24 and 48Â h post-infection. The number of plaque-forming units was determined using standard plaque assaysBack to article page